The Journal for Nurse Practitioners
Volume 2, Issue 6 , Pages 370-378 , June 2006

Evidence-Based Treatment of Diabetic Peripheral Neuropathy

  • Carol Wamboldt, MS, CRNP

      Affiliations

    • Carol Wamboldt, MS, CRNP, is a nurse practitioner at the University of Maryland Hospital in Baltimore, MD.
    • ,
  • Jane Kapustin, PhD-c, CRNP

      Affiliations

    • Jane Kapustin, PhD-c, CRNP, is an assistant of nursing at the University of Maryland in Baltimore where she is the adult nurse practitioner program director.

References 

  1. International Association for the Study of Pain . In:  Merskey H ,  Bogduk N editor. Classification of chronic pain . 2nd ed.. Seattle, Wash: Author; 1994;p. 209–214
  2. Nicholson BD . Diagnosis and management of neuropathic pain: a balanced approach to treatment . J Am Acad Nurse Pract . 2003;15(12 Suppl):3–9
  3. Harstall C , Ospina M . How prevalent is chronic pain? . Pain . 2003;11(2):1–4
  4. Backonja MM , Serra J . Pharmacologic management part 1: better-studied neuropathic pain diseases . Pain Med . 2004;5(Supp1 1):28–47
  5. Renn CL , Dorsey SG . The physiology and processing of pain: a review . AACN Clin Issues . 2005;16(3):277–290
  6. Sima A , Ristic H , Merry A , et al.   Primary and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding worcester rat . J Clin Invest . 1996;97(8):1900–1907
  7. Sheetz MJ , King GL . Molecular understanding of hyperglycemia's adverse effects for diabetic complications . JAMA . 2002;288(20):2579–2588
  8. Bierhaus A , Haslbeck KM , Humpert PM , et al.   Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily . J Clin Invest . 2004;114(12):1741–1751
  9. King RHM . The role of glycation in the pathogenesis of diabetic polyneuropathy . Mol Pathol . 2001;54(16):400–408
  10. Bennett MI , Simpson KH . Gabapentin in the treatment of neuropathic pain . Palliat Med . 2004;18(1):5–11
  11. Dworkin RH , Backonja M , Rowbottom MC , et al.   Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations . Arch Neurol . 2003;60(11):1524–1534
  12. Tatum WO , Galvez R , Benbadis S , Carrazana E . New antiepileptic drugs . Arch Fam Med . 2000;9(10):1135–1141
  13. Washington Department of Labor and Industries & Washington State Medical Association . Guideline for the use of Neurontin in the management of neuropathic pain . Seattle, Wash: Author; 2002;
  14. Barbano RL , Herrmann DN , Hart-Gouleau S , Pennella-Vaughan J , Lodewick PA , Dworkin RH . Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy . Arch Neurol . 2004;61(6):914–918
  15. Vastag B . Scientists find connections in the brain between physical and emotional pain . JAMA . 2003;290(18):2389–2390
  16. Washington Department of Labor and Industries . Guidelines for outpatient prescription of oral opioids for injured workers with chronic, noncancer pain . Olympia, Wash: Author; 2002;
  17. International Research Foundation for RSD/CRPS . Reflex sympathetic dystrophy/complex regional pain syndrome . 3rd ed.. Tampa, Fla: Author; 2003;
  18. Veterans Health Administration & Department of Defense . Va/DoD clinical practice guideline for the management of opioid therapy for chronic pain . Washington, DC: Author; 2003;
  19. The management of persistent pain in older persons . J Am Geriatr Soc . 2002;50(Suppl 6):205–224
  20. Davies PS , Rhiner M . Shooting, burning, stabbing: case studies in neuropathic pain . J Am Acad Nurse Pract . 2005;17(Suppl):7–17
  21. Backonja MM , Serra J . Pharmacologic management part 2: lesser-studied neuropathic pain diseases . Pain Med . 2004;5(Suppl 1):48–59
  22. Rosenstock J , Tuchman M , LaMoreaux L , Sharma U . Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial . Pain . 2004;110(3):628–638
  23. Nicholson B , Verma S . Comorbidities in chronic neuropathic pain . Pain Med . 2004;5(Suppl 1):9–27
  24. Department of Justice . Schedules of controlled substances: placement of pregabalin into schedule V . Federal Register . 2005;70:43633–43635
  25.  Formanek R New drug for neuropathic pain [updates] . FDA Consumer . 2004;38(6):2
  26. Polydefkis M , Griffin JW , McArthur J . New insights into diabetic polyneuropathy . JAMA . 2003;290(10):1371–1376
  27. Hampton T . Researchers probe pathways of pain . JAMA . 2003;290(18):2391–2392
  28. Karst M , Salim K , Burstein S , Conrad I , Hoy L , Schneider U . Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain . JAMA . 2003;290(13):1757–1762

PII: S1555-4155(06)00411-9

doi: 10.1016/j.nurpra.2006.04.015

The Journal for Nurse Practitioners
Volume 2, Issue 6 , Pages 370-378 , June 2006

Article Tools